Belal A. Husein-Al
Irbid, IR 22110, Jordan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
YM155 Restores the Effect of Imatinib in Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines.
Journal: Current cancer drug targets
Published: March 25, 2025
The predictivity of hematological parameters and related inflammatory biomarkers of male subjects with chronic polysubstance use disorder.
Journal: Brain, behavior, & immunity - health
Published: March 24, 2025
Metabolomic Analysis, Antiproliferative, Anti-Migratory, and Anti-Invasive Potential of Amlodipine in Lung Cancer Cells.
Journal: Drug design, development and therapy
Published: June 27, 2024
Prevalence of Medication Associated with QTc Prolongation Used Among Critically Ill Patients.
Journal: Vascular health and risk management
Published: September 27, 2023
Students' experiences and attitudes toward a newly developed simulation-based pharmaceutical care clinical rotation: A pre-post study design.
Journal: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Published: February 01, 2023
Adherence and utilization of short-term antibiotics: Randomized controlled study.
Journal: PloS one
Published: December 25, 2022
Rapid high performance liquid chromatography method for erlotinib quantification in vitro: Application to study the effect of resveratrol on metabolism and cellular uptake of erlotinib.
Journal: Fundamental & clinical pharmacology
Published: November 25, 2022
Photolytic Controlled Release Formulation of Methotrexate Loaded in Chitosan/TiO2 Nanoparticles for Breast Cancer.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: November 16, 2021
Preparation of Modified Chitosan-based Nanoparticles for Efficient Delivery of Doxorubicin and/or Cisplatin to Breast Cancer Cells.
Journal: Current cancer drug targets
Published: June 30, 2021
Depression symptoms and quality of life in patients receiving renal replacement therapy in Jordan: A cross-sectional study.
Journal: Annals of medicine and surgery (2012)
Published: April 06, 2021
Crizotinib induced antitumor activity and synergized with chemotherapy and hormonal drugs in breast cancer cells via downregulating MET and estrogen receptor levels.
Journal: Investigational new drugs
Published: June 20, 2020
Last Updated: 09/26/2026